RxDoctor Payments Data

Weihong Zhao

Physician Assistant · Brooklyn, NYNPI 1669191961

Payments from drug & device makers

$5,892in general payments, 2019–2025

Across 255 payments — averaging $23.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$869
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$713
  • Gilead$692
  • Boehringer Ingelheim$606
  • Exact Sciences$371
  • Esperion Therapeutics, Inc.$348
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$5,892100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,892 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
VascepaIcosapent Ethyl429$161,926
JardianceEmpagliflozin127$101,440
Evenity (2 Syringes)Romosozumab-Aqqg26$61,733
VemlidyTenofovir Alafenamide42$60,454
ProliaDenosumab35$58,349
Diclofenac Epolamine82$54,056
RybelsusSemaglutide42$47,403
JanuviaSitagliptin Phosphate58$38,989
EliquisApixaban50$34,962
FarxigaDapagliflozin Propanediol57$32,338
TrulicityDulaglutide28$29,865
CreonLipase/Protease/Amylase28$14,805
Diclofenac Sodium87$14,391
JanumetSitagliptin Phos/Metformin Hcl16$13,571
XareltoRivaroxaban23$12,413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEvenity (2 Syringes), Prolia$869$120,08261 claims
Boehringer IngelheimJardiance$606$101,440127 claims
GileadVemlidy$692$60,45442 claims
MerckJanuvia, Janumet$224$52,56074 claims
Novo NordiskRybelsus$187$47,40342 claims
PfizerEliquis$326$34,96250 claims
AstraZenecaFarxiga$316$32,33857 claims
Lilly USA, LLCTrulicity$192$29,86528 claims
AbbVieCreon, Linzess$22$24,11346 claims
GSKTrelegy Ellipta, Shingrix$224$15,84848 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →